Treffer 1 - 7 von 7 für Suche 'Nomura‐Yogo, Moe', Suchdauer: 0,66s Treffer weiter einschränken
  1. 1
    Prognostic value of the “dynamic” R2‐ISS in patients with multiple myeloma undergoing anti‐CD38 antibody‐based triplet therapies

    Prognostic value of the “dynamic” R2‐ISS in patients with multiple myeloma undergoing anti‐CD38 antibody‐based triplet therapies von Kikuchi, Taku, Oda, Yuki, Kondo, Ukyo, Tsukada, Nobuhiro, Kunisada, Kodai, Matsumoto, Chiaki, Nomura‐Yogo, Moe, Sato, Kota, Takei, Tomomi, Ogura, Mizuki, Abe, Yu, Suzuki, Kenshi, Hosoya, Osamu, Ishida, Tadao

    Veröffentlicht in Hematological oncology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Adverse impact of 1q amplification on outcomes in patients with multiple myeloma treated with daratumumab, carfilzomib and dexamethasone in a real‐world clinical setting

    Adverse impact of 1q amplification on outcomes in patients with multiple myeloma treated with daratumumab, carfilzomib and dexamethasone in a real‐world clinical setting von Kikuchi, Taku, Tsukada, Nobuhiro, Kunisada, Kodai, Matsumoto, Chiaki, Nomura‐Yogo, Moe, Oda, Yuki, Sato, Kota, Takei, Tomomi, Ogura, Mizuki, Abe, Yu, Suzuki, Kenshi, Hosoya, Osamu, Ishida, Tadao

    Veröffentlicht in Hematological oncology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Local Cytokine Release Syndrome After Idecabtagene Vicleucel Therapy in Patients With Multiple Myeloma: Two Case Reports

    Local Cytokine Release Syndrome After Idecabtagene Vicleucel Therapy in Patients With Multiple Myeloma: Two Case Reports von Kikuchi, Taku, Tsukada, Nobuhiro, Kunisada, Kodai, Nomura-Yogo, Moe, Ishida, Tadao

    Veröffentlicht in Curēus (Palo Alto, CA)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Real-World Clinical Outcomes in Patients With Multiple Myeloma Administered With Elotuzumab-Based Treatment

    Real-World Clinical Outcomes in Patients With Multiple Myeloma Administered With Elotuzumab-Based Treatment von Kikuchi, Taku, Tsukada, Nobuhiro, Oda, Yuki, Nomura-Yogo, Moe, Takei, Tomomi, Sato, Kota, Ogura, Mizuki, Abe, Yu, Suzuki, Kenshi, Ishida, Tadao

    Veröffentlicht in Curēus (Palo Alto, CA)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  5. 5
    Prognostic impact of 1q abnormality on outcomes in patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone in a real-world clinical setting

    Prognostic impact of 1q abnormality on outcomes in patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone in a real-world clinical... von Kikuchi, Taku, Tsukada, Nobuhiro, Kunisada, Kodai, Matsumoto, Chiaki, Nomura-Yogo, Moe, Oda, Yuki, Sato, Kota, Takei, Tomomi, Ogura, Mizuki, Abe, Yu, Suzuki, Kenshi, Hosoya, Osamu, Ishida, Tadao

    Veröffentlicht in Annals of hematology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  6. 6
    Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma

    Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma von Kikuchi, Taku, Tsukada, Nobuhiro, Kunisada, Kodai, Nomura-Yogo, Moe, Oda, Yuki, Sato, Kota, Takei, Tomomi, Ogura, Mizuki, Abe, Yu, Suzuki, Kenshi, Ishida, Tadao


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  7. 7
    Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies

    Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies von Kikuchi, Taku, Tsukada, Nobuhiro, Kunisada, Kodai, Nomura-Yogo, Moe, Oda, Yuki, Sato, Kota, Takei, Tomomi, Ogura, Mizuki, Abe, Yu, Suzuki, Kenshi, Ishida, Tadao

    Veröffentlicht in Annals of hematology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: